P342 Trans-continental analysis of over, 2000 Inflammatory Bowel Disease patients implicates geography, disease type, and exposure to immunosuppression as drivers of SARS-CoV-2 seroprevalence: data from the ICARUS-IBD Consortium
P342 对超过 2000 名炎症性肠病患者的跨大陆分析表明，地理位置、疾病类型和免疫抑制暴露是 SARS-CoV-2 血清阳性率的驱动因素：来自 ICARUS-IBD 联盟的数据
期刊:BMC Rheumatology
影响因子:2.5
doi:10.1186/s41927-020-00161-4
Scott, Ian C; Mount, Julie; Barry, Jane; Kirkham, Bruce; Kearsley-Fleet, Lianne; Jain, Sarthak; Baildam, Eileen; Beresford, Michael W; Douglas, Sharon; Foster, Helen E; Southwood, Taunton R; Hyrich, Kimme L; Wong, S Y; Helmus, D; Marlow, L; Martinez Pazos, V; Brann, S; Wellens, J; Kedia, S; Mak, J W Y; Bergemalm, D; Argollo, M; Zaltman, C; Steinwurz, F; Rubin, D; Allez, M; Halfvarson, J; Abreu, M T; Lindsay, J; Dutta, U; Silverberg, M S; Ng, S C; Ahuja, V; Watanabe, K; Vermeire, S; Colombel, J F; Satsangi, J
